Drug Safety Director Post To Be Filled By Late September, FDA’s Crawford Says
This article was originally published in The Pink Sheet Daily
You may also be interested in...
Crawford Resigns; NCI Director Von Eschenbach Named To Top FDA Spot
Von Eschenbach appointed to be acting FDA commissioner following the Sept. 23 resignation of Lester Crawford.
Crawford Resigns; NCI Director Von Eschenbach Named To Top FDA Spot
Von Eschenbach appointed to be acting FDA commissioner following the Sept. 23 resignation of Lester Crawford.
Drug Safety Oversight Board Proceedings Should Be More Open, Rep. DeLauro Says
FDA Commissioner Crawford defends the board as an "instrument of openness" in response to complaints that the panel's closed proceedings will fail to provide greater transparency.